Glomega works to improve access to novel diagnostics as a basis for advanced diabetes management and diagnostics. The specific topics and cutting edge include:
- Integration of best academic expertise of discovery science to utilize the novel urinary biomarkers in verification studies in various ethnic localities
- Access to special patient sample cohorts of diabetes in China
- Establishment of the best methods to efficiently translate biomarkers into robust biosensor platforms to allow active monitoring of disease progression
- Establishment of links to best available Information and Communication Technologies (ICT) to provide a comprehensive solution for personalized monitoring of health parameters utilizing biosensors
- Providing solutions to Health Account management for diabetics as a Cloud service
- Provide links to best global expertise in bioanalytical sciences, sensor technologies and ICT to comprehensive health maintenance solutions
- Provide an access and expertise in some of the most challenging markets of diabetes: to and from China. This is based on longterm relationship to academic and industrial partners as well as access to Global BioIndustries.
- Outpatient services
HOME / SERVICES / RESEARCH / NEWS / CONTACT
Glomega Inc / info@glomega.fi